Search
Ferroheme C
go.drugbank.com/drugs/DB03317ExperimentalCategories: Heterocyclic Compounds with 4 or More RingsPropyl Gallate
go.drugbank.com/drugs/DB12450InvestigationalPropyl Gallate is under investigation in clinical trial NCT01450098 (A Study of LY2484595 in Healthy Subjects).
Categories: Compounds used in a research, industrial, or household settingGusperimus
go.drugbank.com/drugs/DB12692InvestigationalGusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.
Categories: Compounds used in a research, industrial, or household settingFamphur
go.drugbank.com/drugs/DB11408ExperimentalVet approvedCategories: Compounds used in a research, industrial, or household settingTizaterkib
go.drugbank.com/drugs/DB21296InvestigationalTizaterkib is under investigation in clinical trial NCT04305249 (Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological
Everolimus
go.drugbank.com/drugs/DB01590ApprovedInvestigationalEverolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a simi...
Etybenzatropine
go.drugbank.com/drugs/DB13468ExperimentalCategories: Ethers of Tropine or Tropine Derivatives6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one
go.drugbank.com/drugs/DB08267ExperimentalThe introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. It is known to target queuine tRNA-ribosyltransferase.
Nelotanserin
go.drugbank.com/drugs/DB12555InvestigationalIt increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM or dream sleep.
Vevorisertib
go.drugbank.com/drugs/DB21481InvestigationalVevorisertib is under investigation in clinical trial NCT02761694 (Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations